NSE: SUNPHARMA · Healthcare
Sun Pharma Quarterly Results
Sun Pharma reported sales of ₹16,199 crore for the quarter ended Sep 2026 and net profit of ₹1,995 crore, as compiled by screener.in. Against the same quarter a year earlier (Sep 2025), sales rose 11.9% and net profit fell 36.2%.
Quarterly results (₹ crore)
| Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 12,653 | 13,291 | 13,675 | 12,959 | 13,851 | 14,478 | 15,521 | 14,612 | 15,300 | 16,199 |
| Expenses | 9,045 | 9,352 | 9,666 | 9,243 | 9,550 | 9,951 | 10,572 | 10,658 | 10,882 | 11,455 |
| Operating Profit | 3,608 | 3,939 | 4,009 | 3,716 | 4,302 | 4,527 | 4,948 | 3,954 | 4,418 | 4,744 |
| OPM % | 29% | 30% | 29% | 29% | 31% | 31% | 32% | 27% | 29% | 29% |
| Other Income | 533 | 354 | 149 | 251 | -354 | 470 | 89 | 458 | 520 | -752 |
| Interest | 62 | 69 | 52 | 49 | 75 | 100 | 78 | 86 | 100 | 75 |
| Depreciation | 655 | 626 | 631 | 664 | 701 | 730 | 732 | 775 | 739 | 758 |
| Profit before tax | 3,424 | 3,598 | 3,476 | 3,254 | 3,173 | 4,168 | 4,227 | 3,551 | 4,099 | 3,159 |
| Tax % | 16% | 16% | 16% | 34% | 27% | 25% | 20% | 23% | 29% | 37% |
| Net Profit | 2,861 | 3,037 | 2,913 | 2,154 | 2,293 | 3,125 | 3,381 | 2,710 | 2,901 | 1,995 |
| EPS in Rs | 11.82 | 12.67 | 12.10 | 8.96 | 9.50 | 13.00 | 14.04 | 11.31 | 12.06 | 8.29 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — |
Figures are as reported by the company and compiled by screener.in (fetched 3 Nov 2026, 4:45 pm IST); they may lag the latest filing.
More on Sun Pharma
← Sun Pharma share price and profile
Wondering what to do with Sun Pharma?
This page shares data only. For a view that takes your own holding and goal into account, ask Samjho Bhai, our free portfolio review tool.
Ask Samjho Bhai →Frequently asked questions
What do the quarterly results of Sun Pharma show?
The table lists revenue, expenses, operating profit, net profit and earnings per share for each of the last 10 quarters, in ₹ crore, as compiled by screener.in from the company's filings.
Why can these figures differ from the company's own announcement?
Figures are compiled by a third party and may be rounded, restated or published after a delay. The company's filing on the NSE or BSE is the primary source.
Educational information, not investment advice. Market Dekho is not a SEBI-registered Research Analyst or Investment Adviser. Figures come from public data providers, can be delayed or contain errors, and are shown as facts only.